No Data
No Data
Express News | SciSparc Shares Are Trading Higher After the Company Submitted an Investigational New Drug (IND) Application to the FDA for SCI-110
SciSparc Submitted IND Application to the FDA for SCI-110 Phase IIb Clinical Trial for Patients With Tourette Syndrome
Express News | Scisparc Submitted Ind Application to the FDA for Sci-110 Phase Iib Clinical Trial for Patients With Tourette Syndrome
SciSparc Ltd. Calls for Crucial Shareholder Votes
SciSparc: MitoCareX Appointed Professor Nir Peled, Seasoned Oncologist, to Its Scientific Advisory Board
Express News | Scisparc: Mitocarex Appointed Professor Nir Peled, Seasoned Oncologist, to Its Scientific Advisory Board
No Data